BACKGROUND: Cancer-related fatigue (CRF) is a highly prevalent and underestimated symptom in cancer patients. This study aims to analyze CRF solely in a cohort of oropharyngeal cancer patients who underwent treatment with radiotherapy (RT). METHODS: In January 2008 to June 2010, 87 consecutive oropharyngeal carcinoma patients underwent definitive RT. Concurrent chemotherapy was used for 94% of patients. The median prescription dose to the planning target volume of the gross or clinical tumor volume was 70 Gy for definitive cases (n = 84) and 66 Gy for postoperative cases (n = 3), both delivered over 6.5 weeks. A normalized 12-point numeric rating scale assessed CRF from patient visits before, during, and after RT. RESULTS: The median follow-up of living patients was 14 months. Fatigue peaked 1-2 weeks post-RT and remained higher than baseline for up to 2 years post-RT in 50% of patients. The average fatigue score at the time of completion of therapy or maximum thereafter up to 1 year post-RT was significantly worse than baseline. Patients who experienced pain had a trend toward significance with association for a higher maximum difference in fatigue from baseline. Karnofsky performance status score, weight change, and mood disorders did not correlate with CRF. CONCLUSIONS: Fatigue was a common treatment-related symptom in this uniform cohort of patients with oropharyngeal cancer. RT was highly correlated with worsening of CRF. Pain control has the potential to help mitigate CRF in patients experiencing pain, and will need to be confirmed using larger datasets.
BACKGROUND:Cancer-related fatigue (CRF) is a highly prevalent and underestimated symptom in cancerpatients. This study aims to analyze CRF solely in a cohort of oropharyngeal cancerpatients who underwent treatment with radiotherapy (RT). METHODS: In January 2008 to June 2010, 87 consecutive oropharyngeal carcinomapatients underwent definitive RT. Concurrent chemotherapy was used for 94% of patients. The median prescription dose to the planning target volume of the gross or clinical tumor volume was 70 Gy for definitive cases (n = 84) and 66 Gy for postoperative cases (n = 3), both delivered over 6.5 weeks. A normalized 12-point numeric rating scale assessed CRF from patient visits before, during, and after RT. RESULTS: The median follow-up of living patients was 14 months. Fatigue peaked 1-2 weeks post-RT and remained higher than baseline for up to 2 years post-RT in 50% of patients. The average fatigue score at the time of completion of therapy or maximum thereafter up to 1 year post-RT was significantly worse than baseline. Patients who experienced pain had a trend toward significance with association for a higher maximum difference in fatigue from baseline. Karnofsky performance status score, weight change, and mood disorders did not correlate with CRF. CONCLUSIONS:Fatigue was a common treatment-related symptom in this uniform cohort of patients with oropharyngeal cancer. RT was highly correlated with worsening of CRF. Pain control has the potential to help mitigate CRF in patients experiencing pain, and will need to be confirmed using larger datasets.
Authors: P S Hinds; A Quargnenti; A J Bush; C Pratt; D Fairclough; G Rissmiller; D Betcher; G S Gilchrist Journal: Eur J Oncol Nurs Date: 2000-03 Impact factor: 2.398
Authors: G M Kiebert; D Curran; N K Aaronson; M Bolla; J Menten; E H Rutten; E Nordman; M E Silvestre; M Pierart; A B Karim Journal: Eur J Cancer Date: 1998-11 Impact factor: 9.162
Authors: Canhua Xiao; Jonathan J Beitler; Kristin A Higgins; Karen Conneely; Bhakti Dwivedi; Jennifer Felger; Evanthia C Wommack; Dong M Shin; Nabil F Saba; Luke Yeeloo Ong; Jeanne Kowalski; Deborah W Bruner; Andrew H Miller Journal: Brain Behav Immun Date: 2015-10-30 Impact factor: 7.217
Authors: Matthew J Ferris; Jim Zhong; Jeffrey M Switchenko; Kristin A Higgins; Richard J Cassidy; Mark W McDonald; Bree R Eaton; Kirtesh R Patel; Conor E Steuer; H Michael Baddour; Andrew H Miller; Deborah W Bruner; Canhua Xiao; Jonathan J Beitler Journal: Radiother Oncol Date: 2017-08-18 Impact factor: 6.280
Authors: Heidi Mason; Mary Beth DeRubeis; Nancy Burke; Melissa Shannon; Danielle Karsies; Gregory Wolf; Avi Eisbruch; Francis Worden Journal: World J Clin Oncol Date: 2016-04-10
Authors: Michael J Fisch; Fengmin Zhao; Ann M O'Mara; Xin Shelley Wang; David Cella; Charles S Cleeland Journal: Cancer Date: 2013-10-21 Impact factor: 6.860
Authors: Puja Aggarwal; Katherine A Hutcheson; Ryan P Goepfert; Adam S Garden; Naveen Garg; Frank E Mott; Clifton D Fuller; Stephen Y Lai; Gary Brandon Gunn; Mark S Chambers; Ehab Y Hanna; Erich M Sturgis; Sanjay Shete Journal: Head Neck Date: 2022-01-27 Impact factor: 3.147